Notal Vision
Sagi Bar Nathan is a seasoned engineer with extensive experience in mechanical and process development engineering. Currently serving as a Process Development Engineer at Notal Vision since 2021, Sagi Bar Nathan is responsible for the development and integration of production processes and technical documentation. Previous roles include Mechanical Engineer at Sarine Technologies, where multidisciplinary systems were designed, and Production Engineer at Haargaz TechnoPach, focusing on customer order management and production guidance. Earlier experience encompasses positions such as Mechanical Engineer at Utron, Technical Consultant at Getter Group, Presales Engineer at LYA Hydraulics & Pneumatics Ltd., and Operations Officer in the Israel Defense Forces. Sagi Bar Nathan holds a Bachelor of Science degree in Mechatronics, Robotics, and Automation Engineering from Ariel University.
This person is not in any offices
Notal Vision
Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.